365:
510:
482:
505:
256:
603:
477:
639:
34:
57:, we must rely on the highest quality secondary sources and the recommendations of professional organizations and government bodies when determining the scientific consensus about medical treatments.
446:
434:
458:
249:. The authors are pseudonymous. The findings have not been subject to peer review. We must rely on expert opinion, which describes these sites as unreliable. From published criticisms (
441:
429:
710:
453:
354:
27:
200:
121:
705:
517:
574:
470:
412:
538:
286:
125:
591:
634:
608:
543:
533:
220:
624:
662:
629:
548:
465:
715:
500:
586:
347:
259:
216:
569:
644:
185:
Neither hydroxychloroquine nor chloroquine should be used, either alone or in combination with azithromycin, in inpatient or outpatient settings.
564:
380:
579:
137:
129:
667:
406:
340:
720:
672:
282:
196:
192:
188:
369:
364:
332:
321:
204:
133:
212:
732:
145:
274:
93:
183:. Some data suggest their usage may worsen outcomes. Recommendations from relevant organizations can be summarized:
684:
97:
278:
117:
113:
109:
105:
76:
73:
269:. These analyses include studies which have very small sample sizes, widely different dosages of treatment,
677:
141:
102:
Evidence of efficacy for ivermectin is inconclusive. It should not be used outside of clinical trials.
700:
317:
270:
158:
50:
396:
54:
401:
265:), it is clear that these analyses violate basic methodological norms which are known to
165:
253:
89:
312:
171:
180:
277:, and ad-hoc un-published trials which themselves did not undergo peer-review. (
152:
250:
266:
63:
262:
70:
208:
174:
168:
79:
96:(high certainty) when used to treat COVID-19 in the outpatient setting (
100:). Recommendations from relevant organizations can be summarized as:
179:
These analyses accounted for use both alone and in combination with
336:
177:) demonstrate that neither is effective for treating COVID-19.
273:, different incompatible outcome measures, poor-quality
307:
295:
693:
655:
617:
557:
526:
493:
422:
389:
88:In all likelihood, ivermectin does not reduce
348:
28:
8:
413:Knowledge (XXG)'s response to the pandemic
355:
341:
333:
44:Treatments for COVID-19: Current consensus
35:
21:
18:
184:
101:
7:
86:an effective treatment for COVID-19.
267:cause spurious or false conclusions
14:
363:
92:(moderate certainty) or improve
296:Which pages use this template?
1:
164:The highest quality sources (
69:The highest quality sources (
754:
565:Tips for creating articles
729:
376:
311:) on 27 February 2023 by
82:) suggest Ivermectin is
245:, etc: These sites are
55:Knowledge (XXG) policy
630:Most edited articles
370:WikiProject COVID-19
90:all-cause mortality
668:Project navigation
604:Vaccine Safety Net
518:Recognized content
271:open-label designs
159:hydroxychloroquine
740:
739:
706:Sources guideline
640:Automated reports
478:Wikimedia support
415:
327:
325:
299:
243:trialsitenews.com
231:c19ivermectin.com
745:
733:Project category
721:Biomedical essay
411:
367:
357:
350:
343:
334:
315:
310:
303:
293:
37:
30:
23:
753:
752:
748:
747:
746:
744:
743:
742:
741:
736:
725:
711:Style guideline
689:
651:
613:
553:
522:
489:
418:
385:
384:
372:
361:
331:
330:
329:
328:
306:
301:
300:
94:quality of life
46:
41:
12:
11:
5:
751:
749:
738:
737:
730:
727:
726:
724:
723:
718:
713:
708:
703:
697:
695:
691:
690:
688:
687:
682:
681:
680:
670:
665:
659:
657:
653:
652:
650:
649:
648:
647:
637:
635:Article report
632:
627:
621:
619:
615:
614:
612:
611:
606:
601:
600:
599:
594:
584:
583:
582:
577:
567:
561:
559:
555:
554:
552:
551:
546:
544:Missing topics
541:
536:
534:Article alerts
530:
528:
524:
523:
521:
520:
515:
514:
513:
508:
497:
495:
494:Grading scheme
491:
490:
488:
487:
486:
485:
475:
474:
473:
463:
462:
461:
451:
450:
449:
439:
438:
437:
426:
424:
420:
419:
417:
416:
409:
404:
399:
393:
391:
387:
386:
378:
377:
374:
373:
362:
360:
359:
352:
345:
337:
305:Last updated (
302:
292:
291:
290:
275:control groups
224:
149:
45:
42:
40:
39:
32:
25:
17:
16:
15:
13:
10:
9:
6:
4:
3:
2:
750:
735:
734:
728:
722:
719:
717:
714:
712:
709:
707:
704:
702:
699:
698:
696:
692:
686:
683:
679:
676:
675:
674:
673:User template
671:
669:
666:
664:
661:
660:
658:
654:
646:
643:
642:
641:
638:
636:
633:
631:
628:
626:
625:Popular pages
623:
622:
620:
616:
610:
607:
605:
602:
598:
595:
593:
590:
589:
588:
585:
581:
578:
576:
573:
572:
571:
568:
566:
563:
562:
560:
556:
550:
547:
545:
542:
540:
537:
535:
532:
531:
529:
525:
519:
516:
512:
509:
507:
504:
503:
502:
499:
498:
496:
492:
484:
481:
480:
479:
476:
472:
469:
468:
467:
464:
460:
457:
456:
455:
452:
448:
445:
444:
443:
440:
436:
433:
432:
431:
428:
427:
425:
421:
414:
410:
408:
405:
403:
400:
398:
395:
394:
392:
388:
383:
382:
375:
371:
366:
358:
353:
351:
346:
344:
339:
338:
335:
326:
323:
319:
314:
309:
298:
297:
288:
284:
280:
276:
272:
268:
264:
261:
258:
255:
252:
248:
244:
240:
236:
232:
228:
225:
222:
218:
214:
210:
206:
202:
198:
194:
190:
186:
182:
178:
176:
173:
170:
167:
161:
160:
155:
154:
150:
147:
143:
139:
135:
131:
127:
123:
119:
115:
111:
107:
103:
99:
95:
91:
87:
85:
81:
78:
75:
72:
66:
65:
61:
60:
59:
58:
56:
52:
43:
38:
33:
31:
26:
24:
19:
731:
663:Participants
596:
549:New articles
379:
304:
294:
247:not reliable
246:
242:
238:
234:
230:
226:
181:azithromycin
163:
157:
151:
83:
68:
62:
48:
47:
20:
609:News events
527:Maintenance
442:Translation
423:Task forces
239:hcqmeta.com
227:Ivmmeta.com
153:Chloroquine
53:: Per this
597:treatments
501:Assessment
430:Case Count
235:c19hcq.com
64:Ivermectin
49:A note on
716:COI essay
701:Sanctions
694:Protocols
587:Consensus
558:Resources
539:Deletions
454:Equipment
407:Templates
381:Talk page
189:July 2020
122:July 2021
118:July 2021
114:June 2021
110:June 2021
685:Barnstar
678:survivor
580:lab leak
397:Category
313:Sumanuil
287:Feb 2021
283:Jan 2021
279:Dec 2020
201:May 2021
197:Sep 2020
193:Aug 2020
106:May 2021
51:WP:MEDRS
592:origins
575:overall
570:Sources
511:Quality
390:Content
645:Deaths
402:Portal
368:
156:&
618:Stats
466:Women
656:User
483:talk
471:talk
459:talk
447:talk
435:talk
308:diff
217:ASHP
213:IDSA
138:ASHP
134:IDSA
506:Log
221:NIH
219:,
209:FDA
205:WHO
203:) (
199:,
146:NIH
142:CDC
130:FDA
126:WHO
124:) (
84:not
320:·
285:,
281:,
241:,
237:,
233:,
229:,
215:,
211:,
207:,
195:,
191:,
162::
144:,
140:,
136:,
132:,
128:,
120:,
116:,
112:,
108:,
67::
356:e
349:t
342:v
324:)
322:c
318:t
316:(
289:)
263:5
260:4
257:3
254:2
251:1
223:)
187:(
175:4
172:3
169:2
166:1
148:)
104:(
98:4
80:4
77:3
74:2
71:1
36:e
29:t
22:v
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.